Xtalks Announces its Life Science Webinar Calendar for September 2024
Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, cell and gene therapy, clinical trials, commercialization & HEOR, drug discovery & development, drug safety, healthcare, laboratory technology, medical device, pharma manufacturing & supply chain and pharmaceutical regulation.
TORONTO, Sept. 1, 2024 /PRNewswire-PRWeb/ — Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech and medical device industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!
Visit http://www.xtalks.com to see our upcoming webinars:
BIOMARKERS
September 4 – A New Paradigm in the Detection of Amyloid Pathology: The Emergence of Highly Accurate Blood Tests
September 16 – Advancing Oncology Care: The Evolving Role of Diagnostic Labs in Biomarker-Driven Therapies
CELL AND GENE THERAPY
September 17 – Next-Generation CAR-T Therapies: Optimizing Opportunities and Operationalizing Patient-Centric Oncology Clinical Trials
September 18 – Spatial Visualization of Capsid-Dependent Viral Tropism using RNAscope ISH Technology
CLINICAL TRIALS
September 5 – Advancing Precision Oncology: Radionuclide Conjugate and Antibody-Drug Conjugate (ADC) Development Strategies
September 6 – Sarcopenia: Changes and Challenges in Body Composition with GLP-1 Receptor Agonist-based Weight Loss Therapies
September 9 – Strategic Advantages of Early-Phase Oncology Clinical Development Across Australia and the USA
September 9 – Why Authenticity and Patient Voice Are Critical When Driving Clinical Trial Diversity
September 11 – Beyond Numbers: The Value of In-Trial Interview Data for Regulatory and Health Technology Assessment (HTA) Decision-Making
September 11 – Clinical Data Analysis: Avoiding Obstacles to Success
September 12 – How Artificial Intelligence is Transforming Clinical Development
September 13 – Streamlining Clinical Trial Imaging Workflows: From Collection to Completion
September 16 – Shifting Ophthalmology Retina Market: Proactive Planning for Late-Stage Clinical Success
September 17 – Accelerating Clinical Product Development through Centralized Content Work Streams
September 17 – Advancing MS Clinical Trials: Integrating Medical Imaging, Precision Motion Analysis, and eCOA Data for Enhanced Outcomes
September 19 – Patient First: Enhancing Strategies for Effective Patient Engagement, Recruitment and Diversity in Clinical Trials
September 24 – Community-Based Research Series: Engaging New-to-Research Physicians within Community Healthcare
September 26 – Bridging the Gap: Direct-to-Patient Strategies to Support Diversity in Clinical Trials
September 30 – From Extra to Essential: Scaling Mobile Apps for Future-Proofed Patient Engagement and Universal Sponsor Adoption
COMMERCIALIZATION & HEOR
September 5 – Driving Commercial Success for Precision Medicine: Understand the Market to Maximize Patient Identification and Therapy Adoption
DRUG DISCOVERY & DEVELOPMENT
September 4 – The Power of DNA Mutant Libraries: Accelerating Revolution in Research
September 9 – Enabling Clinical Programs Through Antibody Glycosylation
September 10 – Mastering the Art of Developing a Successful Bispecific Antibody
September 18 – Accelerating Neurodegenerative Clinical Drug Development with AI
September 19 – New Era of Obesity Drug Development
September 23 – Advancing Epilepsy Research: New Strategies for Drug-Resistant Epilepsy and Associated Comorbidities
September 27 – Global R&D Insights in Drug Development: Insights from Industry on the Future of Pharma
DRUG SAFETY
September 12 – Mastering RMPs and RMMs: Tech-driven solutions for patient safety
HEALTHCARE
September 20 – Digital Health Tools That Will Transform Cancer Treatment
LABORATORY TECHNOLOGY
September 13 – Criticality of STAT Osmolality Testing: Identifying Toxic Alcohol Ingestion
September 16 – Enhancing NGS Sample Preparation from Sample to the Sequencer
September 30 – Exploring the Range of Electron Microscopes: Resolution, Size and Users
MEDICAL DEVICE
September 12 – Changes are Coming to Prefilled Injectable Drug Delivery Systems
September 25 – Key Pathology Considerations for Successful Preclinical Medical Device Studies, from Protocol to Report
September 30 – Creating Software as a Medical Device (SaMD) Technology in the Ever Changing Regulatory Environment
PHARMA MANUFACTURING & SUPPLY CHAIN
September 4 – Considerations for Oligonucleotide Therapeutics in CMC
September 11 – Advanced AAV Processing and Potency through Characterisation of Capsid and Payload Heterogeneity
September 26 – Quality by Design in mRNA Manufacturing
PHARMACEUTICAL REGULATION
September 10 – Regulatory Submission Writing for NDA Success
September 20 – Medicare Part D Price Negotiation Update
September 24 – Compliance Risk in Technology: How Can IT and Quality Teams Root it Out
September 24 – The Journey to Approval: Navigating the Road from EoP2 to NDA Submission
September 25 – The New Era of Project Optimus: Implications for Oncology Development Strategy
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://www.xtalks.com/
Media Contact
Ayesha Rashid, Xtalks, +1 (416) 977-6555 x272, arashid@xtalks.com, https://www.xtalks.com/
View original content to download multimedia:https://www.prweb.com/releases/xtalks-announces-its-life-science-webinar-calendar-for-september-2024-302235364.html
SOURCE Xtalks
Disclaimer: The above press release comes to you under an arrangement with PR Newswire. USA Newshour takes no editorial responsibility for the same.
